Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Non–β-hemolytic Streptococcal Bacteremia in Patients With Heart Valve Prosthesis—Is It Always Infective Endocarditis?

Toivonen, Fanni LU ; Sunnerhagen, Torgny LU orcid ; Lundin, Johannes ; Bläckberg, Anna LU ; Ragnarsson, Sigurdur LU and Rasmussen, Magnus LU orcid (2025) In Open Forum Infectious Diseases 12(5). p.1-7
Abstract
Introduction
Non-beta-haemolytic streptococci are among the most common causative agents of infective endocarditis (IE). Patients with a heart valve prosthesis (HVP) have a high risk of IE. We aimed to determine the risk for IE in patients with HVP and non-beta-haemolytic streptococcal bacteraemia (NBHSB), and to study NBHSB relapse depending on treatment duration.
Method
Adults with HVP and NBHSB 2015—2018 in the region of Skåne, Sweden, were identified through the Clinical Microbiology Laboratory in Lund and were evaluated in a population-based investigation. Data were collected from medical records according to a pre-defined protocol.
Results
A total of 110 NBHSB episodes in 89 patients with HVP were included. In 40... (More)
Introduction
Non-beta-haemolytic streptococci are among the most common causative agents of infective endocarditis (IE). Patients with a heart valve prosthesis (HVP) have a high risk of IE. We aimed to determine the risk for IE in patients with HVP and non-beta-haemolytic streptococcal bacteraemia (NBHSB), and to study NBHSB relapse depending on treatment duration.
Method
Adults with HVP and NBHSB 2015—2018 in the region of Skåne, Sweden, were identified through the Clinical Microbiology Laboratory in Lund and were evaluated in a population-based investigation. Data were collected from medical records according to a pre-defined protocol.
Results
A total of 110 NBHSB episodes in 89 patients with HVP were included. In 40 episodes (36%), the patients had definite IE, in 69 possible IE, and one had rejected IE according to the European Society of Cardiology 2015 criteria. Twenty-eight of the 70 patients (40%) without a definite diagnosis of IE were treated with antibiotics as if they had IE. There were seven NBHSB relapses, and six of these occurred in patients with possible IE. Four of the relapses occurred in patients who received antibiotics for less than 14 days. Three patients with possible IE were diagnosed with definite IE at the time of the relapse.
Conclusion
Patients with NBHSB and HVP have a high risk for IE and should be thoroughly investigated. Most patients with NBHSB and HVP who fulfilled criteria for possible IE did not receive long-course antibiotic treatment. Moreover, some patients treated with a short course of antibiotics experienced NBHSB relapse. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Open Forum Infectious Diseases
volume
12
issue
5
article number
ofaf242
pages
1 - 7
publisher
Oxford University Press
ISSN
2328-8957
DOI
10.1093/ofid/ofaf242
language
English
LU publication?
yes
id
66deb499-555b-40bc-93fe-2be1970b5cf7
date added to LUP
2025-04-18 12:49:06
date last changed
2025-05-19 07:29:29
@article{66deb499-555b-40bc-93fe-2be1970b5cf7,
  abstract     = {{Introduction<br/>Non-beta-haemolytic streptococci are among the most common causative agents of infective endocarditis (IE). Patients with a heart valve prosthesis (HVP) have a high risk of IE. We aimed to determine the risk for IE in patients with HVP and non-beta-haemolytic streptococcal bacteraemia (NBHSB), and to study NBHSB relapse depending on treatment duration.<br/>Method<br/>Adults with HVP and NBHSB 2015—2018 in the region of Skåne, Sweden, were identified through the Clinical Microbiology Laboratory in Lund and were evaluated in a population-based investigation. Data were collected from medical records according to a pre-defined protocol.<br/>Results<br/>A total of 110 NBHSB episodes in 89 patients with HVP were included. In 40 episodes (36%), the patients had definite IE, in 69 possible IE, and one had rejected IE according to the European Society of Cardiology 2015 criteria. Twenty-eight of the 70 patients (40%) without a definite diagnosis of IE were treated with antibiotics as if they had IE. There were seven NBHSB relapses, and six of these occurred in patients with possible IE. Four of the relapses occurred in patients who received antibiotics for less than 14 days. Three patients with possible IE were diagnosed with definite IE at the time of the relapse.<br/>Conclusion<br/>Patients with NBHSB and HVP have a high risk for IE and should be thoroughly investigated. Most patients with NBHSB and HVP who fulfilled criteria for possible IE did not receive long-course antibiotic treatment. Moreover, some patients treated with a short course of antibiotics experienced NBHSB relapse.}},
  author       = {{Toivonen, Fanni and Sunnerhagen, Torgny and Lundin, Johannes and Bläckberg, Anna and Ragnarsson, Sigurdur and Rasmussen, Magnus}},
  issn         = {{2328-8957}},
  language     = {{eng}},
  number       = {{5}},
  pages        = {{1--7}},
  publisher    = {{Oxford University Press}},
  series       = {{Open Forum Infectious Diseases}},
  title        = {{Non–β-hemolytic Streptococcal Bacteremia in Patients With Heart Valve Prosthesis—Is It Always Infective Endocarditis?}},
  url          = {{https://lup.lub.lu.se/search/files/219088336/ofaf242.pdf}},
  doi          = {{10.1093/ofid/ofaf242}},
  volume       = {{12}},
  year         = {{2025}},
}